TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2018

Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma.

Luciano J Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.